Lighthouse Investment Partners, LLC Eli Lilly & CO Transaction History

Lighthouse Investment Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $14.4 Million - $18 Million	19,804 Added 345.38%	25,538 $23.1 Million
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $2.87 Million - $3.84 Million	-4,848 Reduced 45.81%	5,734 $4.46 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $1.06 Million - $1.25 Million	2,014 Added 23.51%	10,582 $6.17 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $3.72 Million - $5.13 Million	8,568 New	8,568 $4.6 Million

4,004

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Lighthouse Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Lighthouse Investment Partners, LLC with notifications on news.